Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A <italic toggle="yes">Streptococcus</italic> Virulence

ABSTRACT Streptolysin O is a potent pore-forming toxin produced by group A Streptococcus. The aims of the present study were to dissect the relative contributions of different structural domains of the protein to hemolytic activity, to obtain a detoxified form of streptolysin O amenable to human vac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Emiliano Chiarot, Cristina Faralla, Nico Chiappini, Giovanna Tuscano, Fabiana Falugi, Gabriella Gambellini, Annarita Taddei, Sabrina Capo, Elena Cartocci, Daniele Veggi, Alessia Corrado, Simona Mangiavacchi, Simona Tavarini, Maria Scarselli, Robert Janulczyk, Guido Grandi, Immaculada Margarit, Giuliano Bensi
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2013
Materias:
Acceso en línea:https://doaj.org/article/bb3003ecff814c90b395fe26d22ddb65
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:bb3003ecff814c90b395fe26d22ddb65
record_format dspace
spelling oai:doaj.org-article:bb3003ecff814c90b395fe26d22ddb652021-11-15T15:40:23ZTargeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A <italic toggle="yes">Streptococcus</italic> Virulence10.1128/mBio.00387-122150-7511https://doaj.org/article/bb3003ecff814c90b395fe26d22ddb652013-03-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00387-12https://doaj.org/toc/2150-7511ABSTRACT Streptolysin O is a potent pore-forming toxin produced by group A Streptococcus. The aims of the present study were to dissect the relative contributions of different structural domains of the protein to hemolytic activity, to obtain a detoxified form of streptolysin O amenable to human vaccine formulation, and to investigate the role of streptolysin O-specific antibodies in protection against group A Streptococcus infection. On the basis of in silico structural predictions, we introduced two amino acid substitutions, one in the proline-rich domain 1 and the other in the conserved undecapeptide loop in domain 4. The resulting streptolysin O derivative showed no toxicity, was highly impaired in binding to eukaryotic cells, and was unable to form organized oligomeric structures on the cell surface. However, it was fully capable of conferring consistent protection in a murine model of group A Streptococcus infection. When we engineered a streptococcal strain to express the double-mutated streptolysin O, a drastic reduction in virulence as well as a diminished capacity to kill immune cells recruited at the infection site was observed. Furthermore, when mice immunized with the toxoid were challenged with the wild-type and mutant strains, protection only against the wild-type strain, not against the strain expressing the double-mutated streptolysin O, was obtained. We conclude that protection occurs by antibody-mediated neutralization of active toxin. IMPORTANCE We present a novel example of structural design of a vaccine antigen optimized for human vaccine use. Having previously demonstrated that immunization of mice with streptolysin O elicits a protective immune response against infection with group A Streptococcus strains of different serotypes, we developed in this study a double-mutated nontoxic derivative that represents a novel tool for the development of protective vaccine formulations against this important human pathogen. Furthermore, the innovative construction of an isogenic strain expressing a functionally inactive toxin and its use in infection and opsonophagocytosis experiments allowed us to investigate the mechanism by which streptolysin O mediates protection against group A Streptococcus. Finally, the ability of this toxin to directly attack and kill host immune cells during infection was studied in an air pouch model, which allowed parallel quantification of cellular recruitment, vitality, and cytokine release at the infection site.Emiliano ChiarotCristina FarallaNico ChiappiniGiovanna TuscanoFabiana FalugiGabriella GambelliniAnnarita TaddeiSabrina CapoElena CartocciDaniele VeggiAlessia CorradoSimona MangiavacchiSimona TavariniMaria ScarselliRobert JanulczykGuido GrandiImmaculada MargaritGiuliano BensiAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 4, Iss 1 (2013)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Emiliano Chiarot
Cristina Faralla
Nico Chiappini
Giovanna Tuscano
Fabiana Falugi
Gabriella Gambellini
Annarita Taddei
Sabrina Capo
Elena Cartocci
Daniele Veggi
Alessia Corrado
Simona Mangiavacchi
Simona Tavarini
Maria Scarselli
Robert Janulczyk
Guido Grandi
Immaculada Margarit
Giuliano Bensi
Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A <italic toggle="yes">Streptococcus</italic> Virulence
description ABSTRACT Streptolysin O is a potent pore-forming toxin produced by group A Streptococcus. The aims of the present study were to dissect the relative contributions of different structural domains of the protein to hemolytic activity, to obtain a detoxified form of streptolysin O amenable to human vaccine formulation, and to investigate the role of streptolysin O-specific antibodies in protection against group A Streptococcus infection. On the basis of in silico structural predictions, we introduced two amino acid substitutions, one in the proline-rich domain 1 and the other in the conserved undecapeptide loop in domain 4. The resulting streptolysin O derivative showed no toxicity, was highly impaired in binding to eukaryotic cells, and was unable to form organized oligomeric structures on the cell surface. However, it was fully capable of conferring consistent protection in a murine model of group A Streptococcus infection. When we engineered a streptococcal strain to express the double-mutated streptolysin O, a drastic reduction in virulence as well as a diminished capacity to kill immune cells recruited at the infection site was observed. Furthermore, when mice immunized with the toxoid were challenged with the wild-type and mutant strains, protection only against the wild-type strain, not against the strain expressing the double-mutated streptolysin O, was obtained. We conclude that protection occurs by antibody-mediated neutralization of active toxin. IMPORTANCE We present a novel example of structural design of a vaccine antigen optimized for human vaccine use. Having previously demonstrated that immunization of mice with streptolysin O elicits a protective immune response against infection with group A Streptococcus strains of different serotypes, we developed in this study a double-mutated nontoxic derivative that represents a novel tool for the development of protective vaccine formulations against this important human pathogen. Furthermore, the innovative construction of an isogenic strain expressing a functionally inactive toxin and its use in infection and opsonophagocytosis experiments allowed us to investigate the mechanism by which streptolysin O mediates protection against group A Streptococcus. Finally, the ability of this toxin to directly attack and kill host immune cells during infection was studied in an air pouch model, which allowed parallel quantification of cellular recruitment, vitality, and cytokine release at the infection site.
format article
author Emiliano Chiarot
Cristina Faralla
Nico Chiappini
Giovanna Tuscano
Fabiana Falugi
Gabriella Gambellini
Annarita Taddei
Sabrina Capo
Elena Cartocci
Daniele Veggi
Alessia Corrado
Simona Mangiavacchi
Simona Tavarini
Maria Scarselli
Robert Janulczyk
Guido Grandi
Immaculada Margarit
Giuliano Bensi
author_facet Emiliano Chiarot
Cristina Faralla
Nico Chiappini
Giovanna Tuscano
Fabiana Falugi
Gabriella Gambellini
Annarita Taddei
Sabrina Capo
Elena Cartocci
Daniele Veggi
Alessia Corrado
Simona Mangiavacchi
Simona Tavarini
Maria Scarselli
Robert Janulczyk
Guido Grandi
Immaculada Margarit
Giuliano Bensi
author_sort Emiliano Chiarot
title Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A <italic toggle="yes">Streptococcus</italic> Virulence
title_short Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A <italic toggle="yes">Streptococcus</italic> Virulence
title_full Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A <italic toggle="yes">Streptococcus</italic> Virulence
title_fullStr Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A <italic toggle="yes">Streptococcus</italic> Virulence
title_full_unstemmed Targeted Amino Acid Substitutions Impair Streptolysin O Toxicity and Group A <italic toggle="yes">Streptococcus</italic> Virulence
title_sort targeted amino acid substitutions impair streptolysin o toxicity and group a <italic toggle="yes">streptococcus</italic> virulence
publisher American Society for Microbiology
publishDate 2013
url https://doaj.org/article/bb3003ecff814c90b395fe26d22ddb65
work_keys_str_mv AT emilianochiarot targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT cristinafaralla targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT nicochiappini targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT giovannatuscano targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT fabianafalugi targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT gabriellagambellini targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT annaritataddei targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT sabrinacapo targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT elenacartocci targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT danieleveggi targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT alessiacorrado targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT simonamangiavacchi targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT simonatavarini targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT mariascarselli targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT robertjanulczyk targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT guidograndi targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT immaculadamargarit targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
AT giulianobensi targetedaminoacidsubstitutionsimpairstreptolysinotoxicityandgroupaitalictoggleyesstreptococcusitalicvirulence
_version_ 1718427791309930496